Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 13, 2026
JPMorgan Chase (JPM): Breaking Down the Path to a $375 Target and +13% Upside

JPMorgan Chase (JPM): Breaking Down the Path to a $375 Target and +13% Upside

Key Takeaways

  • Price Target in Focus: $375 per share — a level endorsed by TD Cowen as recently as December 2025 and representing roughly 13% upside from JPMorgan Chase's current price near $330.
  • Strongest Bullish Factors: Market-leading investment banking franchise, robust return on tangible common equity (ROTCE) above 20%, aggressive share buybacks, and continued growth across wealth management and trading.
  • Biggest Obstacles: Elevated valuation relative to historical averages, uncertainty surrounding CEO Jamie Dimon's eventual succession, potential net interest margin compression if interest rates decline, and rising regulatory costs.
  • Key Technical Levels: The 52-week high near $343 serves as immediate resistance. A sustained breakout above that level would be required before $375 becomes a realistic near-term target.
  • Bottom Line for Investors: Reaching $375 is plausible over a multi-year horizon if earnings growth continues at its current pace, but the stock's valuation expansion over the past three years means much of the upside must now come from fundamental execution rather than multiple expansion.

Why the $375 Level Matters to Me

The $375 price target has drawn attention because TD Cowen, which rates JPMorgan Chase & Co. (JPM) as its "Top Pick Among Money Center Banks," raised its target to that level in December 2025. With JPM currently trading near $330, hitting $375 would require a gain of approximately 13.5% — ambitious but not unprecedented for a stock that delivered a 37% return in 2025 and a 44% gain in 2024. The question now is whether the same drivers that powered that rally remain in place, or whether the easy gains have already been captured. I also checked this setup using Tickeron’s AI Pattern Search Engine to see how recent price action aligns with historical patterns.

Company Snapshot

JPMorgan Chase is the largest bank in the United States by assets, operating across three core segments: Consumer and Community Banking, the Commercial and Investment Bank (CIB), and Asset and Wealth Management. With a balance sheet exceeding $4.9 trillion, over $2.68 trillion in deposits, and more than $7.1 trillion in client assets under management, JPM holds the top global ranking in investment banking fees with an 8.4% market share. The firm employs roughly 318,000 people across 66 countries and is widely regarded as the bellwether for the American banking sector.

Where the Stock Stands Today

JPMorgan Chase stock currently trades at approximately $330.62, near the upper end of its 52-week range of $279.10 to $343.45. The shares have pulled back modestly from their recent peak but remain up substantially over multi-year timeframes — posting a 137.5% total return over three years and 106.7% over five years. The stock carries a price-to-earnings (P/E) ratio of approximately 16x trailing earnings, above the 10-year historical average of roughly 11.6x. This elevated multiple reflects the market's confidence in JPM's competitive position but also sets a higher bar for future stock price appreciation.

Factors That Could Push JPM Toward $375

Several forces could propel the stock toward the $375 target. First, JPMorgan's Commercial and Investment Bank continues to gain market share, with TD Cowen highlighting the firm's Kinexys operating platform as "one of the most valuable strategic assets in the industry." A sustained recovery in mergers and acquisitions (M&A) activity and capital markets would directly boost investment banking fees, which were already showing a robust rebound in late 2025. I also ran a quick comparison here with Tickeron’s AI Screener to see how JPM stacks up against peers on fee revenue trends.

Second, the wealth and asset management division has demonstrated impressive momentum, with client investment assets growing 14% year-over-year and assets under management climbing 18%. As global wealth expands, this segment should continue generating higher-margin fee revenue. Third, JPMorgan's aggressive capital return program — including $8 billion in quarterly net share repurchases and a dividend that has been maintained for 55 consecutive years — provides a steady tailwind for per-share metrics.

Finally, the bank's investments in tokenization, digital payments infrastructure, and stablecoin technology position it to remain competitive against fintech disruptors rather than losing ground to them. If these technology bets translate into sustained revenue growth and margin improvements, the earnings power required to support a $375 valuation becomes increasingly credible.

Obstacles That Could Block the Move

The path to $375 is not without significant hurdles. Valuation presents the most immediate concern. JPMorgan's price-to-book ratio of approximately 2.6x stands well above its 10-year average of about 1.5x, meaning investors are already pricing in a considerable premium for the bank's competitive advantages. Any disappointment in earnings growth, credit quality, or expense management could trigger multiple compression that would make reaching $375 substantially more difficult even if the underlying business performs adequately.

Interest rate uncertainty represents another major variable. While JPMorgan has navigated the rate environment skillfully, aggressive rate cuts by the Federal Reserve would compress net interest margins and reduce net interest income — a core earnings driver. Additionally, rising credit loss provisions in consumer lending, particularly in credit cards, could weigh on profitability if the macroeconomic environment deteriorates. The succession question surrounding longtime CEO Jamie Dimon also looms as one of the financial sector's largest key-person risks.

Analyst Views and Price Targets

Wall Street sentiment on JPMorgan Chase remains broadly constructive, though far from unanimous. The consensus analyst rating stands at "Outperform," with a one-year average price target of approximately $352, according to aggregated data. Individual targets show meaningful dispersion: Goldman Sachs raised its target to $366, Keefe Bruyette & Woods set a target of $363, Wells Fargo lifted its target to $350, and UBS maintained a Buy rating with a $350 target. On the more cautious side, Morgan Stanley maintains an Equal-Weight rating and describes the stock as "full" at current levels, while Truist Securities holds a Hold rating with a $330 target.

TD Cowen's $375 target represents the high end of mainstream analyst forecasts and is predicated on continued market share gains in the CIB division and what the firm considers a bargain valuation at 14.2x estimated 2027 earnings. The gap between the average target of roughly $352 and the $375 objective illustrates that reaching the higher figure will require outperformance relative to the current consensus outlook.

Technical Levels Worth Watching

From a technical perspective, the most important level on the chart is the 52-week high around $343.45 — which also coincides with the stock's all-time high zone. This area represents a clear resistance level that must be decisively broken before any sustained move toward $375 can materialize. On the downside, the $300 psychological round number and the $279 area, which marks the 52-week low, serve as major support zones. The stock's long-term trend remains firmly intact, characterized by a series of higher highs and higher lows over multiple years. However, the recent consolidation below $343 suggests that buyers have not yet mustered enough conviction to push the stock into new territory. One thing that stands out when I review the chart is how cleanly the all-time high has held so far.

Valuation Perspective

At roughly 16x trailing earnings and 2.6x book value, JPMorgan Chase commands a premium that reflects its status as the premier franchise in American banking. Some valuation models — particularly those using excess returns frameworks — suggest intrinsic values as high as $428 per share, implying the stock remains undervalued even after its multi-year rally. However, more conservative approaches that anchor valuations to historical multiples suggest the stock is fairly valued to modestly overvalued. Achieving $375 would imply a P/E multiple in the range of 17-18x forward earnings, which is achievable if ROTCE remains above 20% and the market continues rewarding consistent execution — but leaves limited room for error.

Risks to Keep in Mind

Beyond valuation and interest rate sensitivity, investors should weigh several additional risks. Regulatory changes could increase capital requirements or compliance costs, compressing returns. Competition from private credit markets and well-funded fintech firms could erode JPM's fee and lending economics over time. The eventual CEO transition represents an unpredictable variable that markets may not fully price in until a clear succession timeline emerges. Finally, a broader economic slowdown would likely increase loan loss provisions and weigh on trading and advisory revenues, dampening the earnings trajectory needed to support a $375 stock price.

Using AI Daily Buy/Sell Signals for JPM

Navigating a stock like JPMorgan Chase requires staying ahead of shifting market dynamics, and AI Daily Buy/Sell Signals from Tickeron offer a data-driven solution. This product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving technical patterns, market conditions, and AI-powered analysis. Rather than relying on manually scanning charts, traders can use these signals to spot emerging opportunities, track existing positions, and identify trend changes with greater efficiency. For investors looking to stay informed on names like JPM without spending hours on technical research, exploring Tickeron's AI Daily Buy/Sell Signals can be a practical next step. In my experience, layering these signals with fundamental work helps keep the analysis grounded.

Final Assessment

The $375 price target for JPMorgan Chase is ambitious but not far-fetched. It requires the bank to continue executing at a high level across its investment banking, wealth management, and consumer franchises while the macroeconomic environment remains supportive. The strongest arguments in favor of reaching this level include JPMorgan's dominant market position, its consistent ability to generate returns on tangible common equity above 20%, and its aggressive capital return strategy. However, elevated valuation multiples, the eventual CEO succession, and uncertainty around the interest rate trajectory all represent meaningful obstacles. Investors should monitor the stock's ability to break above its $343 all-time high resistance zone, the trajectory of investment banking fees, and any developments regarding succession planning. While $375 is achievable over a multi-year timeframe under favorable conditions, the journey from $330 to $375 will likely require tangible earnings growth rather than further expansion of already-elevated valuation multiples.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: JPM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


JPM's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for JPM turned positive on August 12, 2026. Looking at past instances where JPM's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on JPM as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JPM advanced for three days, in of 359 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 319 cases where JPM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JPM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

JPM broke above its upper Bollinger Band on July 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 19, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. JPM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: JPM's P/B Ratio (2.746) is slightly higher than the industry average of (1.977). P/E Ratio (15.646) is within average values for comparable stocks, (16.541). Projected Growth (PEG Ratio) (1.786) is also within normal values, averaging (1.641). JPM has a moderately low Dividend Yield (0.016) as compared to the industry average of (0.025). P/S Ratio (5.115) is also within normal values, averaging (4.413).

Notable companies

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Bank of America Corp (NYSE:BAC), HSBC Holdings PLC (NYSE:HSBC), Wells Fargo & Co (NYSE:WFC), Citigroup (NYSE:C), Barclays PLC (NYSE:BCS).

Industry description

Major banks are among the biggest companies in the world, often times with global reach and market capitalizations in the multi-billions. Large banks often have multiple arms spanning different disciplines, from deposits, to investment banking, to wealth management and insurance. The biggest banks often have key competitive advantages over smaller players in the industry in terms of brand recognition, cost of capital, and efficiency. Think J.P. Morgan, Bank of America, Wells Fargo, and Citigroup.

Market Cap

The average market capitalization across the Major Banks Industry is 220.18B. The market cap for tickers in the group ranges from 1.04M to 970.72B. JPM holds the highest valuation in this group at 970.72B. The lowest valued company is BACRP at 1.04M.

High and low price notable news

The average weekly price growth across all stocks in the Major Banks Industry was 2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 24%. NTB experienced the highest price growth at 3%, while FRBT experienced the biggest fall at -1%.

Volume

The average weekly volume growth across all stocks in the Major Banks Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was -21% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 29
Price Growth Rating: 40
SMR Rating: 7
Profit Risk Rating: 19
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
JPM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a major bank

Industry MajorBanks

Profile
Details
Industry
Major Banks
Address
383 Madison Avenue
Phone
+1 212 270-6000
Employees
309926
Web
https://www.jpmorganchase.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.